I'm sorry, I just saw your post. I will do the best that I can to explain these tests to you.
1) TSH 3rd generation = thyroid hormone test. Secretion of the thyroid hormone T4 (thyroxine) by the thyroid is regulated by TSH which is, in turn, secreted by the pituitary.First generation TSH assays have detection limits of about 5 to 10 mU/L. Since the normal range for TSH is about 0.5 to 5.0 mU/L, these assays often miss mild hypothyroidism (where the TSH is usually just above 5) and are totally inadequate for assessment of hyperthyroidism (where the TSH is usually below 0.5). As a result, most laboratories have stopped using the first generation TSH assay.
Second generation TSH assays have a lower detection limit of about 0.1 mU/L. These assays distinguish normal from hypothyroid patients with a high degree of accuracy. Since the detection limit is just below the normal range for TSH of about 0.5 to 5.0 mU/L, these assays can also be used as screening tests to distinguish hyperthyroidism from normal thyroid function. Second generation assays are currently in wide use.
Third generation TSH assays have become available with detection limits of about 0.01 mU/L. Because of the considerably lower detection limit, these assays can reliably distinguish between normal and hyperthyroid patients. Because the distinction between normal and hyperthyroid patients is usually not a problem, these assays have limited value and are not widely utilized.
2) hCG/Beta Subunit, Quant = This test is used as a tumor marker for certain cancers. It is used to evaluate and monitor male individuals with testicular tumors. This test is also used to determine the presence of hCG in individuals with gestational trophoblastic disease.
3) Hep B Surface Antibody= Also known as: HBV; Hep B; anti-HBs; Hepatitis B surface antibody; HBsAg; Hepatitis B surface antigen; HBeAg; Hepatitis B e antigen; anti-HBc; Hepatitis B core antibody; anti-HBc, IgM; anti-HBe; Hepatitis B e antibody; HBV DNA - used to detect antibodies produced in response to HBV infection; some detect antigens produced by the virus, and others detect viral DNA. Generally, one set of tests is used to determine the cause of acute symptoms while another set of tests may be used after a diagnosis is made, to monitor possible progression of the disease, to detect chronic infection and/or carrier status.
4) Hep C Antibody = Also known as: Hepatitis C antibody; anti-HCV; HCV recombinant immunoblot assay; HCV RIBA; HCV-RNA; Hepatitis C viral load - used to detect and diagnose an infection and/or to monitor the treatment of hepatitis C virus (HCV). Detects the presence of antibodies to the virus, indicating exposure to HCV. This test cannot distinguish between someone with an active or a previous HCV infection. Usually, the test is reported as "positive" or "negative." There is some evidence that if the test is "weakly positive," it may be a false positive. The Centers for Disease Control and Prevention (CDC) suggests that weakly positive tests be confirmed with the HCV RIBA test before being reported.
5) HIV-1/0/2 Antibodies = The ADVIA Centaur HIV 1/O/2 Assay is an immunoassay for the qualitative detection of antibodies to human immunodeficiency virus (HIV) type 1 (including group 0), and type 2 in human serum and plasma using the ADVIA Centaur Immunoassay System. The ADVIA Centaur HIV assay may be used in conjunction with other serological and clinical information to aid in the diagnosis of individuals with symptoms of HIV type 1 (including Group 0), and type 2 in individuals at risk for human immunodeficiency virus infection.
6) Rheumatoid Arthritis Factor = The rheumatoid factor (RF) test is primarily used to help diagnose rheumatoid arthritis (RA) and other connective tissue diseases, such as Lupus, to distinguish it from other forms of arthritis and other conditions that cause similar symptoms of joint pain, inflammation, and stiffness. It may be ordered along with other autoimmune-related tests, such as an ANA (antinuclear antibody), along with other markers of inflammation, such as a CRP (C-reactive protein) and ESR (erythrocyte sedimentation rate), and along with a CBC (Complete Blood Count) to evaluate the body’s blood cells. A CCP (Cyclic Citrullinated Peptide Antibody) test, a relatively new test that can help detect early RA, may be ordered if the RF is negative. The RF test may also be ordered, along with tests such as anti-SS-A and anti-SS-B to help diagnose Sjögren’s syndrome.
7) RPR = Rapid plasma reagin, a blood test for syphilis that looks for an antibody that is present in the bloodstream when a patient has syphilis. A negative (nonreactive) RPR is compatible with a person not having syphilis, but in the early stages of the disease, the RPR often gives false negative results. Conversely, a false positive RPR can be encountered in infectious mononucleosis, lupus, antiphospholipid antibody syndrome, hepatitis A, leprosy, malaria and, occasionally, pregnancy.
8) CRP = C Reactive Protein test, is one of the four essential blood tests in determining your risk for developing heart disease and for inflammation disease (such as Lupus). CRP abnormal test results could be an indication of inflammation in the blood.
9) SSA & SSB antibodies = The SSA antigen is also referred to as the "Ro/SSA" antigen. When SSA is found in combination with the SSB (la) antigen, it commonly points to Sjögren's Syndrome. In the book "The New Sjögren's Syndrome Handbook" author Daniel J. Wallace points out that a patient who tests positive for the SSA and SSB antigens on a blood test for Sjögren's Syndrome usually also tests positive for the antinuclear antigen (ANA). The test that is given to identify SSA and SSB antigens in the blood stream often includes a CBC (complete blood count) as well as a liver and kidney function reading, blood glucose level reading and a Rheumatoid Factor (RF) reading. According to ClinLab Navigator, one tube of blood is needed to perform an SSA blood test, and the findings are recorded as either a positive or negative blood result.
10) Complement C3 & C4 = The complement system is one of the natural defense mechanisms that protects the human body from infections and perhaps tumors. Quantitative measurement of complement
components aids in the diagnosis of immunologic disorders, especially those associated with deficiencies of complement components. The clinical presentation of patients with complement abnormalitites usually falls into one of four categories: 1) multisystem rheumatic disease such as systemic lupus erthematosus
(SLE), 2) glomerulonephritis; 3) hemolytic anemia or, 4) recurrent or overwhelming infections.
C3 and C4 are used to determine whether deficiencies or abnormalities in the complement system are causing, or contributing to, a disease or condition. Total complement activity (CH50, or CH100) may be ordered to look at the integrity of the entire classical complement pathway. Other complement components are ordered as needed to look for deficiencies
11) anti ds DNA & Antismith antibodies = Patients with SLE synthesize a variety of different autoantibodies, many of which react with well-characterized nuclear antigens (table 1). Some of these antibodies are also found in patients with other connective tissue diseases. As an example, antibodies to DNA/histone may be seen in patients with rheumatoid arthritis, anti-RNP antibodies in mixed connective tissue disease, and anti-Ro/SSA antibodies in Sjögren's syndrome. Such antibodies may be present for a few years before clinically apparent disease develops. Several of the other antinuclear antibodies reportedly specific for SLE are found in a small number of patients, and are therefore impractical for use as a screening test
Look For The Good and Praise It!